Technical Analysis for SLP - Simulations Plus, Inc.
|Grade||Last Price||% Change||Price Change|
SLP closed up 1.87 percent on Friday, January 18, 2019, on approximately normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline. The stock crossed above its 200 day moving average, improving its long-term outlook by crossing above that critical trendline.
|Weak or Absent||Up||Up||Down|
|See historical SLP trend table...|
|Date||Alert Name||Type||% Chg|
|Jan 18||Death Cross||Bearish||0.00%|
|Jan 18||Crossed Above 200 DMA||Bullish||0.00%|
|Jan 18||Crossed Above 50 DMA||Bullish||0.00%|
|Jan 18||Calm After Storm||Range Contraction||0.00%|
|Jan 18||NR7||Range Contraction||0.00%|
|Jan 17||50 DMA Resistance||Bearish||1.87%|
|Jan 17||Fell Below 200 DMA||Bearish||1.87%|
|Jan 17||20 DMA Support||Bullish||1.87%|
|Jan 17||Spinning Top||Other||1.87%|
|Jan 17||Calm After Storm||Range Contraction||1.87%|
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicatorsBasic chart:
Simulations Plus, Inc. designs and develops pharmaceutical simulation software for use in the pharmaceutical research and in the education of pharmacy and medical students. The company's products include ADMET Predictor, a computer program that takes molecular structures as inputs and predicts their properties; MedChem Designer, a molecule drawing program or sketcher; MedChem Studio, a tool for data mining and designing new drug-like molecules by medicinal and computational chemists; DDDPlus, which simulates in vitro laboratory experiments that measure the rate of dissolution of the drug and additives contained in tablets and capsules; and GastroPlus that simulates the absorption, pharmacokinetics, and pharmacodynamics of drugs administered to humans and animals. It also develops and sells Abbreviate!, a productivity software program, as well as offers consulting and contract research services to the pharmaceutical industry. The company operates in North America, Europe, Asia, and South America. Simulations Plus, Inc. was founded in 1996 and is headquartered in Lancaster, California.
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more SLP news...
|52 Week High||23.95|
|52 Week Low||14.25|
|200-Day Moving Average||19.4765|
|50-Day Moving Average||19.4648|
|20-Day Moving Average||19.2|
|10-Day Moving Average||19.711|
|Average True Range||0.992|
|Chandelier Exit (Long, 3 ATRs )||18.024|
|Chandelier Exit (Short, 3 ATRs )||20.156|
|Upper Bollinger Band||20.898|
|Lower Bollinger Band||17.502|
|Percent B (%b)||0.62|
|MACD Signal Line||0.0762|
|Market Cap||338 Million|
|Num Shares||17.2 Million|
|Price-to-Earnings (P/E) Ratio||63.23|
|Pivot Point Level||Traditional / Classic||Fibonacci||Demark||Woodie||Camarilla|
|Resistance 4 (R4)||20.68|
|Resistance 3 (R3)||20.69||20.34||20.50|
|Resistance 2 (R2)||20.34||20.06||20.34||20.44|
|Resistance 1 (R1)||19.97||19.90||20.16||19.96||20.38|
|Support 1 (S1)||19.25||19.34||19.44||19.24||18.82|
|Support 2 (S2)||18.90||19.18||18.90||18.76|
|Support 3 (S3)||18.53||18.90||18.70|
|Support 4 (S4)||18.52|